Nasal Long-Term Inhalation Therapy: Treating the respiratory tract during sleep

Millions of people with chronic respiratory diseases such as asthma and COPD are among the most vulnerable to the corona pandemic. The best protection is offered by an optimally adjusted therapy of the inflamed lung areas – and this could receive an innovative boost through Nasal Long-Term Inhalation therapy (NLI therapy), which is currently being developed in Marburg.